Nia-Chrom and Ombitasvir, paritaprevir, ritonavir and dasabuvir
Determining the interaction of Nia-Chrom and Ombitasvir, paritaprevir, ritonavir and dasabuvir and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: chromium picolinate
Brand name: Cr-GTF, CRM, Chromium GTF
Synonyms: Chromium picolinate, Chromium
Generic Name: dasabuvir / ombitasvir / paritaprevir / ritonavir
Brand name: Viekira XR, Viekira Pak
Synonyms: Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets, and Dasabuvir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Nia-Chrom-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Nia-Chrom-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Nia-Chrom-Omeclamox-Pak
- Nia-Chrom-Omega-3 Fatty Acid Capsules
- Nia-Chrom-Omega-3 Fatty Acids
- Nia-Chrom-Omega-3 polyunsaturated fatty acids
- Ombitasvir, paritaprevir, ritonavir and dasabuvir-Niacin
- Ombitasvir, paritaprevir, ritonavir and dasabuvir-Niacin and Lovastatin
- Ombitasvir, paritaprevir, ritonavir and dasabuvir-Niacin and Simvastatin
- Ombitasvir, paritaprevir, ritonavir and dasabuvir-Niacin Capsules and Tablets
- Ombitasvir, paritaprevir, ritonavir and dasabuvir-Niacin Controlled-Release Capsules and Controlled-Release Tablets
- Ombitasvir, paritaprevir, ritonavir and dasabuvir-Niacin SR